Oxbow Advisors LLC boosted its position in The Cigna Group (NYSE:CI - Free Report) by 17.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,188 shares of the health services provider's stock after purchasing an additional 2,855 shares during the period. Oxbow Advisors LLC's holdings in The Cigna Group were worth $5,299,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. AMF Tjanstepension AB increased its stake in shares of The Cigna Group by 18.6% during the 3rd quarter. AMF Tjanstepension AB now owns 73,600 shares of the health services provider's stock worth $25,511,000 after purchasing an additional 11,550 shares in the last quarter. Swedbank AB increased its position in The Cigna Group by 26.6% during the third quarter. Swedbank AB now owns 570,283 shares of the health services provider's stock worth $197,569,000 after buying an additional 119,681 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of The Cigna Group by 7.0% in the third quarter. Sequoia Financial Advisors LLC now owns 4,948 shares of the health services provider's stock worth $1,714,000 after acquiring an additional 322 shares during the last quarter. International Assets Investment Management LLC boosted its stake in shares of The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider's stock valued at $138,590,000 after acquiring an additional 399,230 shares during the last quarter. Finally, YHB Investment Advisors Inc. increased its position in The Cigna Group by 18.7% during the 3rd quarter. YHB Investment Advisors Inc. now owns 2,303 shares of the health services provider's stock worth $798,000 after purchasing an additional 363 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms have issued reports on CI. Deutsche Bank Aktiengesellschaft decreased their price target on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a research note on Monday, November 4th. Oppenheimer lowered their price target on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a research report on Friday, January 31st. Sanford C. Bernstein downgraded shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price for the company. in a research report on Thursday, February 6th. UBS Group reduced their target price on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Finally, Truist Financial decreased their price target on The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a report on Tuesday, February 4th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $372.31.
Get Our Latest Analysis on The Cigna Group
The Cigna Group Stock Performance
NYSE:CI traded up $2.49 during trading hours on Monday, reaching $302.30. 803,215 shares of the stock were exchanged, compared to its average volume of 1,777,286. The stock has a market capitalization of $84.09 billion, a P/E ratio of 24.68, a P/E/G ratio of 0.98 and a beta of 0.54. The firm has a 50 day simple moving average of $286.35 and a 200-day simple moving average of $319.47. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the firm earned $6.79 EPS. As a group, sell-side analysts forecast that The Cigna Group will post 29.77 earnings per share for the current fiscal year.
The Cigna Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 dividend on an annualized basis and a yield of 2.00%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio (DPR) is currently 49.35%.
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.